Cart
sales@molnova.com
Nylestriol
CAS No. 39791-20-3
Nylestriol( Lilly 49825 | LY 49825 | LY-49825 | LY49825 | Nilestriolum )
Catalog No. M27324 CAS No. 39791-20-3
Nylestriol is an agonist of estrogen receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 49 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 106 | In Stock |
|
| 50MG | 152 | In Stock |
|
| 100MG | 226 | In Stock |
|
| 200MG | 321 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNylestriol
-
NoteResearch use only, not for human use.
-
Brief DescriptionNylestriol is an agonist of estrogen receptor.
-
DescriptionNylestriol is an agonist of estrogen receptor.(In Vivo):Nylestriol promoted formation of new bone, increase bone density, and improve bone microstructure damage in OVX rats when combining with Simvastatin.
-
In Vitro——
-
In Vivo——
-
SynonymsLilly 49825 | LY 49825 | LY-49825 | LY49825 | Nilestriolum
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorIsocitrate Dehydrogenase (IDH)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39791-20-3
-
Formula Weight380.528
-
Molecular FormulaC25H32O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@]12CC[C@H]3[C@@H](CCc4cc(OC5CCCC5)ccc34)[C@@H]1C[C@@H](O)[C@@]2(O)C#C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huangshu, et al. 3-Pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH and their preparation. WO2013046136A1
molnova catalog
related products
-
ARV-471
ARV-471 is a best-in-class, orally active Cereblon -based estrogen receptor ( ER ) PROTAC degrader. ARV-471 is developed for the research of breast cancer.
-
Norgestrel
Norgestrel is a synthetic progestin commonly used alone or in combination with an estrogen for contraception.
-
H3B-5942
H3B-5942 is an orally available, selective estrogen receptor covalent antagonist (SERCA), demonstrates potent ERαantagonist activity in vitro and in vivo.
